The aim of this randomized, double-blind trial was to evaluate the safety and tolerability profle, including cardiac safety, of sugammadex-mediated recovery from neuromuscular block in participants undergoing surgery who met the American Society of Anesthesiologists (ASA) Physical Class 3 or 4 criteria. Specifcally, this study assessed the impact of sugammadex on cardiac adverse events (AEs) and other prespecifed AEs of clinical interest. |